Atopic Keratoconjunctivitis (AKC) or Atopic Dermatitis Patients
Currently Enrolling
This study involves 7 visits over the course of approximately 18 weeks. You may also have the option to continue in the study for an additional 4 visits.
If you complete all 7 visits, you will be compensated $945 for your time. If you complete all 11 visits, you will be compensated $1,485 for your time. If you do not qualify to complete all of the visits, you will be paid for each visit that you come into the office for.
Andover, MA
Smyrna, TN
Shelby, NC
Kansas City, MO
Great Neck, NY
Bala Cynwyd, PA
Littleton, CO
Los Angeles, CA
Hollywood, FL
Ann Arbor, MI
Round Rock, TX
Springfield, MO
Hawthorne, NY
We are adding new locations for this study regularly. Please fill out the form below to learn more.
This study is intended for people who have signs and symptoms of Atopic Keratoconjunctivitis (AKC). Common symptoms of AKC are red, burning or itchy eyes and excessive tearing or sensitivity to light.
The purpose of this study is to evaluate how effective subcutaneous injections or “shots” (applied under the skin) of an investigational drug are compared to placebo (drug without the active ingredient) for the treatment of the signs and symptoms of AKC.
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.
